1. 尊龙凯时-人生就是搏!「CHINA」官方网站

    No results.

    HTDK to Attend LSI Asia, Empowering Global MedTech Innovation to Thrive in China

    17 Apr 2025

    From June 10–13, 2025, the inaugural LSI Asia, hosted by global healthcare innovation platform Life Science Intelligence (LSI), will take place in Singapore. As a pioneer in introducing overseas MedTech innovations and driving their commercialization in China, HTDK will attend the summit as part of the “Mednovation 萬疆創新” VIP delegation, alongside fellow member companies of the CIIE Medical Device Committee. Together with global MedTech innovators, investors, and multinational healthcare leaders, HTDK will explore new opportunities for cross-border collaboration and work to accelerate the successful localization of high-potential medical technologies in China.

    Asia Pacific in Focus: The Next Global Growth Engine

    LSI’s decision to launch its Asia Summit underscores the region’s rising importance on the global MedTech map. Asia-Pacific (APAC) is now the second-largest MedTech market in the world, reaching USD 131 billion in 2023, with a compound annual growth rate (CAGR) nearly twice that of the US and Europe. From 2023 to 2028, the APAC MedTech market is expected to grow at a robust 8.4% CAGR, becoming a major engine for global healthcare development.

    China, in particular, plays a pivotal role in this shift. According to LSI Market Intelligence, China is projected to surpass the United States in total surgical procedure volume in 2024, and will join India, South Korea, and Singapore as one of the world’s five fastest-growing markets in procedure volume. This marks a fundamental transformation—APAC is no longer just an “emerging” player, but a core driver of global MedTech growth.

    As LSI’s CEO Scott Pantel stated:
    “We’re seeing China and the broader Asia-Pacific region evolve rapidly—from ‘me too’ markets into major global sources of original innovation in Deep Tech, AI, robotics, and beyond.”

    HTDK: Bridging Global Innovation with the Chinese Market

    As a leading cross-border MedTech commercialization platform, HTDK is committed to helping overseas medical technology companies succeed in China through comprehensive, end-to-end solutions. These services include regulatory compliance, market access, supply chain execution, digital integration, and commercial operations—ensuring that innovation not only enters China, but thrives and scales sustainably.

    “Our participation in LSI Asia reflects HTDK’s long-term commitment to building a gateway between global innovation and China’s dynamic healthcare ecosystem,” said Teresa Chen, CEO of HTDK. “We look forward to forming new partnerships and co-creating a MedTech innovation pathway that is both deeply rooted in China and globally connected.”

    As globalization and healthcare transformation continue to accelerate, HTDK will remain a strategic connector and catalyst, helping global MedTech innovations take root, grow, and flourish in one of the world’s most dynamic healthcare markets.

    info@ahhttx.com
    +86 21 6033 9588

    23F, Building A
    The New Bund World Trade Center
    No 4, Lane 255 Dongyu Road
    Pudong New District, Shanghai, China 200126